Vacunas y actividades preventivas en pacientes con artritis inflamatorias

  1. Casals Sánchez, José Luis
  2. Casals Vázquez, Cristina
  3. Vázquez Sánchez, María de los Angeles
  4. Giménez Basallote, S.
Zeitschrift:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Datum der Publikation: 2013

Nummer: 7

Seiten: 382-385

Art: Artikel

DOI: 10.1016/J.SEMERG.2013.01.008 DIALNET GOOGLE SCHOLAR

Andere Publikationen in: Semergen: revista española de medicina de familia

Zusammenfassung

Patients with inflammatory arthritis and eligible for immunosuppressive therapy account for more than 1% of general population, and represents a significant workload on family doctors. They are prone to other comorbidities, with an increased cardiovascular risk and a higher incidence of infections than the general population, especially skin infections and pneumonitis. This comorbidity can be considered vulnerable to a prevention program, prevention of cardiovascular risk, cancer screening, vaccination schedule for adults. As for prevention through vaccination, importance should be given to pneumococcal infection, significant in adults aged 50 or over, especially amongst immunosuppressed patients. The 13-valent conjugate vaccine, which has been recently approved for adults, must be considered. An attempt has been made to write a simple, applicable document on preventive measures that should be implemented both at primary and secondary care level for those adults.